Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging (Q43815610)

27 November 2017

Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging (English)

1 reference

27 November 2017

1 reference

12

1 reference

27 November 2017

Arian Mashhood

1

1 reference

27 November 2017

Radha Railkar

2

1 reference

27 November 2017

Takeshi Yokoo

3

1 reference

27 November 2017

Yakir Levin

4

1 reference

27 November 2017

Lisa Clark

5

1 reference

27 November 2017

Sabrina Fox-Bosetti

6

1 reference

27 November 2017

Michael S Middleton

7

1 reference

27 November 2017

Jonathan Riek

8

1 reference

27 November 2017

Eunkyung Kauh

9

1 reference

27 November 2017

Bernard J Dardzinski

10

1 reference

27 November 2017

Donald Williams

11

1 reference

27 November 2017

Norah J Shire

13

1 reference

27 November 2017

21 November 2012

1 reference

Journal of Magnetic Resonance Imaging

27 November 2017

1 reference

27 November 2017

37

1 reference

27 November 2017

6

1 reference

27 November 2017

1359-1370

1 reference

describes a project that uses

27 November 2017

magnetic resonance imaging

1 reference

based on heuristic

inferred from title

cites work

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Novel insights into the pathophysiology of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Effect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Simple proton spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

In vivo characterization of the liver fat ¹H MR spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Relaxation effects in the quantification of fat using gradient echo imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Non-alcoholic steatohepatitis in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Cost-effectiveness of treatments for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Infection complicating percutaneous liver biopsy in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23928

21 January 2018

Identifiers

DOI

10.1002/JMRI.23928

1 reference

27 November 2017

1 reference